AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

However, a non-functional sellar mass can initially present with hypopituitarism. The patient being described is an elderly female who presented with severe hyponatraemia. She has history of recurrent ...

Raising awareness of the risk of post-traumatic hypopituitarism following a head injury must be increased among healthcare professionals, say campaigners. Thousands of people, in the UK alone ...

Medical treatment is initially based upon the use of corticosteroids to treat the inflammatory process. Ordinarily, this is given in the form of high-dose prednisone or equivalent steroids ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

People living in England are eligible for free prescriptions, if they are aged 60 or over, are under 16 or 16 to 18 and in ...

People living in England are eligible for free prescriptions, if they are aged 60 or over, are under 16 or 16 to 18 and in full-time education.

Female pattern baldness (androgenetic alopecia) is the most common cause of hair loss in women, but there are many other potential causes. Some effective treatment options are available. Hair loss ...

In March 2025, Checkpoint announced that it entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Sun Pharmaceutical Industries, Inc. (“Sun Pharma”), and a wholly ...

EGRIFTA WR™ (tesamorelin for injection) is approved in the U.S. for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy*. EGRIFTA WR™ is a growth hormone- releasing ...

The dad has a young daughter with a rare medical condition. And while his platform is something very different, he’s decided to use what already exists to shed light on what his ...